Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

European project opens way for better understanding of human diseases

21.02.2002


In the edition of Nature dated Thursday 21 February 2002, an international team of scientists report their analysis of the genome of fission yeast (Schizosaccharomyces pombe). The project, largely funded through a €6.9 million from the European Commission, is likely to have major implications for the future of cancer and other bio-medical research. Fifty of the yeast genes were found to have significant similarity with genes involved in human diseases, including cystic fibrosis, hereditary deafness and non insulin dependent diabetes, and half were found to be cancer related. Because yeast cells are similar to human cells but easier to study, this work is leading to a better understanding of what each gene controls, and how they may be involved in cancer and other diseases in humans.



Research Commissioner Philippe Busquin commented this scientific breakthrough saying: "This type of research is yet another example for the strong link between scientic advancement and practical use for the citizen. Unlike other genomics projects, Europe has taken the leading role in this research through networking of the best. That is precisely what I have been advocating since the Lisbon summit in spring 2000, where I proposed to create a European Research Area."

Schizosaccharomyces pombe is known as fission yeast because it reproduces by splitting rather than by budding like Saccharomyces cerevisiae (baker`s yeast), and is occasionally used for brewing beer. Like man, it is an eukaryote, i.e. an organism that, unlike bacteria, contains its genome in a nucleus inside the cell and is generally thought to be more complex.


The completion of the sequence and analysis of this genome is the result of the joint effort of 13 European laboratories led by the Wellcome Trust Sanger Institute which sequenced two-thirds of the genome and did the gene predictions and annotation for all of the sequence. The global analysis of the genome was performed jointly by Cancer Research UK and the Sanger Institute. The second phase of the sequencing was carried out by a European Consortium led by the Sanger Institute. The consortium consisted of major European laboratories that also contributed to the S. cerevisiae genome project. The majority of funding for the project was from the European Commission (€6.9 million out of a total budget of €9.4 million).

The 133 authors of the Nature paper include Dr Paul Nurse of Cancer Research UK, whose work on fission yeast and cell division recently led to the award for the Nobel prize for Medicine, and Dr Bart Barrell and Val Wood from the Wellcome Trust Sanger Institute near Cambridge.

Dr Nurse stated: `Biomedicine depends on our study of model organisms, which can provide key insights into the way in which the more complex human genome works. The genome fission yeast is only the sixth higher (eukaryotic) life form to be decoded. Significantly, many decisions the humble yeast cell makes in cell division use genes that are closely related to genes implicated in many human cancers: this small organism could prove vital in helping to better understand and treat cancer and other diseases.`

Val Wood, from the Wellcome Trust Sanger Institute, commented: `Each step in our study of genomes brings new and surprising understanding of the common basis that underlies the way cells work. In this international collaboration we have provided high-quality sequence and precise analysis of the genes buried in the fission yeast genetic code, demonstrating the value of sharing genomic information. Through this shared effort, the genome of S. pombe is one of the best annotated of any non-bacterial cell. As well as finding cancer-related genes, we have begun to illustrate how other functions in this, perhaps the simplest complex cell, can bring new tools to understanding ourselves and our place in evolution.`

The joint effort to sequence and analyse the sequence of a micro-organism to better understand and improve human health is a typical an example of the continuing European effort in the area of Genomics and Biotechnology for Health. Building on such major achievements, the European Commission proposes to allocate €2.2 billion to this priority in the forthcoming Sixth Framework Programme (2002-2006).

Stéphane Hogan | alphagalileo
Further information:
http://www.sanger.ac.uk/Projects/S_pombe/

More articles from Health and Medicine:

nachricht Hot cars can hit deadly temperatures in as little as one hour
24.05.2018 | Arizona State University

nachricht 3D images of cancer cells in the body: Medical physicists from Halle present new method
16.05.2018 | Martin-Luther-Universität Halle-Wittenberg

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Powerful IT security for the car of the future – research alliance develops new approaches

The more electronics steer, accelerate and brake cars, the more important it is to protect them against cyber-attacks. That is why 15 partners from industry and academia will work together over the next three years on new approaches to IT security in self-driving cars. The joint project goes by the name Security For Connected, Autonomous Cars (SecForCARs) and has funding of €7.2 million from the German Federal Ministry of Education and Research. Infineon is leading the project.

Vehicles already offer diverse communication interfaces and more and more automated functions, such as distance and lane-keeping assist systems. At the same...

Im Focus: Molecular switch will facilitate the development of pioneering electro-optical devices

A research team led by physicists at the Technical University of Munich (TUM) has developed molecular nanoswitches that can be toggled between two structurally different states using an applied voltage. They can serve as the basis for a pioneering class of devices that could replace silicon-based components with organic molecules.

The development of new electronic technologies drives the incessant reduction of functional component sizes. In the context of an international collaborative...

Im Focus: LZH showcases laser material processing of tomorrow at the LASYS 2018

At the LASYS 2018, from June 5th to 7th, the Laser Zentrum Hannover e.V. (LZH) will be showcasing processes for the laser material processing of tomorrow in hall 4 at stand 4E75. With blown bomb shells the LZH will present first results of a research project on civil security.

At this year's LASYS, the LZH will exhibit light-based processes such as cutting, welding, ablation and structuring as well as additive manufacturing for...

Im Focus: Self-illuminating pixels for a new display generation

There are videos on the internet that can make one marvel at technology. For example, a smartphone is casually bent around the arm or a thin-film display is rolled in all directions and with almost every diameter. From the user's point of view, this looks fantastic. From a professional point of view, however, the question arises: Is that already possible?

At Display Week 2018, scientists from the Fraunhofer Institute for Applied Polymer Research IAP will be demonstrating today’s technological possibilities and...

Im Focus: Explanation for puzzling quantum oscillations has been found

So-called quantum many-body scars allow quantum systems to stay out of equilibrium much longer, explaining experiment | Study published in Nature Physics

Recently, researchers from Harvard and MIT succeeded in trapping a record 53 atoms and individually controlling their quantum state, realizing what is called a...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

In focus: Climate adapted plants

25.05.2018 | Event News

Save the date: Forum European Neuroscience – 07-11 July 2018 in Berlin, Germany

02.05.2018 | Event News

Invitation to the upcoming "Current Topics in Bioinformatics: Big Data in Genomics and Medicine"

13.04.2018 | Event News

 
Latest News

In focus: Climate adapted plants

25.05.2018 | Event News

Flow probes from the 3D printer

25.05.2018 | Machine Engineering

Less is more? Gene switch for healthy aging found

25.05.2018 | Life Sciences

VideoLinks
Science & Research
Overview of more VideoLinks >>>